Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03590821 · ClinicalTrials.gov registry record · Early Phase 1
Timed Aspirin Chronobiome Study
A Early Phase 1 study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT03590821: Clinical Trial Early Phase 1 study, sponsored by University of Pennsylvania.
NCT03590821 is a Early Phase 1 study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 60 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03590821, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
To determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.
Primary Outcome
Ambulatory blood pressure measurements
Interventions
- DRUG Aspirin 81 mg
- DRUG Celecoxib 200mg capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2027-12 |
| Est. Completion | 2028-11 |
| Phase | Early Phase 1 |
What is known before NCT03590821 opens enrollment
NCT03590821 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% higher).
The record links to 0 conditions, and to 2 interventions - of which Aspirin 81 mg is the first listed.
NCT03590821 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03590821 about?
NCT03590821 is a clinical study titled "Timed Aspirin Chronobiome Study". To determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.
What is the current status of trial NCT03590821?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2027-12. Estimated completion is 2028-11.
What interventions are being tested in trial NCT03590821?
The interventions under investigation include: Aspirin 81 mg (DRUG), Celecoxib 200mg capsule (DRUG).
Who is sponsoring clinical trial NCT03590821?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03590821's enrollment target sits among peer trials
60 403rd of 2000 higher than 1,564 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia